A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

Clinical trial NCT04840680 · COMPLETED

Trial details

NCT number: NCT04840680
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2021-03-22
Primary completion: 2023-07-06
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.